Background Stroke thrombolysis with alteplase is currently recommended 0–4· 5 h after
stroke onset. We aimed to determine whether perfusion imaging can identify patients with …

Importance Intravenous thrombolysis with tenecteplase improves reperfusion prior to
endovascular thrombectomy for ischemic stroke compared with alteplase. Objective To …

Background and Purpose—Rapid reperfusion with mechanical thrombectomy in ischemic
strokes with emergent large vessel occlusions leads to significant reduction in morbidity and …

Introduction Several ECG markers are postulated to represent underlying atrial remodelling
and have been associated with ischemic stroke. P-wave terminal force in lead V 1 (PTFV 1) …

Background Reducing door‐to‐needle time (DNT) for intravenous thrombolysis in acute
ischaemic stroke can lead to improved patient outcomes. Long‐term reports on DNT trends …

Background and Purpose—The use of thrombolysis in acute minor ischemic stroke (MIS)
remains controversial. We sought to determine the safety and efficacy of intravenous tissue …

Objective Recent anticoagulation trials in all-comer cryptogenic stroke patients have yielded
equivocal results, reinvigorating the focus on identifying reproducible markers of an atrial …

Background Thrombolytic therapy in patients with pre-existing disability presenting with
acute ischemic stroke (AIS) is controversial because of concerns regarding poor outcomes …

Aim To determine the reliability of DOASENSE by comparing its results and acquisition time
metrics to expedited standard laboratory plasma DOAC level assays. Method In accordance …

Acute ischaemic strokes occur despite the use of direct oral anticoagulants (DOACs). A
retrospective review was conducted at a high‐volume primary stroke centre over a 3‐year …